Laxabon Norveška - norveški - Statens legemiddelverk

laxabon

farmagon - makrogol 3350 / natriumsulfat / natriumhydrogenkarbonat / natriumklorid / kaliumklorid - pulver til mikstur, oppløsning - 59 g / 5.69 g / 1.71 g / 1.44 g / 0.75 g

Plenvu Norveška - norveški - Statens legemiddelverk

plenvu

norgine b.v. - makrogol 3350 / natriumaskorbat / natriumsulfat, vannfritt / askorbinsyre / natriumklorid / kaliumklorid - pulver til mikstur, oppløsning - 140 g / 48.11 g / 9 g / 7.54 g / 5.2 g / 2.2 g

Livmarli Europska Unija - norveški - EMA (European Medicines Agency)

livmarli

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.

Xyrem Europska Unija - norveški - EMA (European Medicines Agency)

xyrem

ucb pharma ltd - natriumoksybat - cataplexy; narcolepsy - andre nervesystemet narkotika - behandling av narkolepsi med katapleksi hos voksne pasienter.

Promixin 1 mill IE Norveška - norveški - Statens legemiddelverk

promixin 1 mill ie

zambon spa - kolistimetatnatrium - pulver til infusjonsvæske, oppløsning - 1 mill ie

Isoprenaline hydrochloride Macure 0.2 mg/ ml Norveška - norveški - Statens legemiddelverk

isoprenaline hydrochloride macure 0.2 mg/ ml

macure pharma aps - isoprenalinhydroklorid - konsentrat til infusjonsvæske, oppløsning - 0.2 mg/ ml

Salidex 2.92 g/ L / 35 g/ L Norveška - norveški - Statens legemiddelverk

salidex 2.92 g/ l / 35 g/ l

b. braun melsungen ag - natriumklorid / glukose - infusjonsvæske, oppløsning - 2.92 g/ l / 35 g/ l

Fenylefrin Unimedic 0.05 mg/ ml Norveška - norveški - Statens legemiddelverk

fenylefrin unimedic 0.05 mg/ ml

unimedic pharma ab - fenylefrinhydroklorid - injeksjonsvæske, oppløsning - 0.05 mg/ ml

Fenylefrin Unimedic 0.1 mg/ ml Norveška - norveški - Statens legemiddelverk

fenylefrin unimedic 0.1 mg/ ml

unimedic pharma ab - fenylefrinhydroklorid - injeksjonsvæske, oppløsning - 0.1 mg/ ml

Sapropterin Dipharma Europska Unija - norveški - EMA (European Medicines Agency)

sapropterin dipharma

dipharma arzneimittel gmbh - sapropterin dihydrochloride - phenylketonurias - andre alimentary tract and metabolism products, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.